Compare Chemfab Alka. with Similar Stocks
Dashboard
Poor long term growth as Operating profit has grown by an annual rate -28.88% of over the last 5 years
The company has declared negative results for the last 11 consecutive quarters
With ROCE of 1.8, it has a Expensive valuation with a 1.2 Enterprise value to Capital Employed
Underperformed the market in the last 1 year
Stock DNA
Commodity Chemicals
INR 497 Cr (Micro Cap)
NA (Loss Making)
37
0.34%
0.29
0.82%
1.35
Total Returns (Price + Dividend) 
Latest dividend: 1.2 per share ex-dividend date: Sep-04-2025
Risk Adjusted Returns v/s 
Returns Beta
News

Chemfab Alkalis Ltd Falls to 52-Week Low of Rs 330.8 as Sell-Off Deepens
For the third consecutive session, Chemfab Alkalis Ltd has declined sharply, hitting a fresh 52-week low of Rs 330.8 on 23 Mar 2026. This drop extends the stock’s year-long slide, which now stands at a steep -55.21%, far outpacing the broader market’s modest -5.47% loss over the same period.
Read full news article
Chemfab Alkalis Ltd is Rated Strong Sell
Chemfab Alkalis Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 07 July 2025. However, the analysis and financial metrics presented here reflect the stock's current position as of 21 March 2026, providing investors with the latest insights into the company’s performance and outlook.
Read full news article
Chemfab Alkalis Ltd Technical Momentum Shifts Amid Bearish Market Sentiment
Chemfab Alkalis Ltd, a micro-cap player in the commodity chemicals sector, has experienced a nuanced shift in its technical momentum, reflecting a complex interplay of bearish and mildly bullish signals. Despite a recent downgrade to a Strong Sell rating, the stock’s technical indicators reveal a mixed picture that warrants close attention from investors navigating volatile market conditions.
Read full news article Announcements 
Announcement under Regulation 30 (LODR)-Credit Rating
14-Mar-2026 | Source : BSESubmission of Credit Rating Letter issued by India Ratings and Research (Ind-Ra) in respect of the Companys banking facilities.
Announcement under Regulation 30 (LODR)-Newspaper Publication
30-Jan-2026 | Source : BSESubmission of newspaper clippings on publication of unaudited financial results for the quarter and nine months ended 31st December 2025
Submission Of Investor Presentation
29-Jan-2026 | Source : BSESubmission of investor presentation for the quarter ended 31st December 2025
Corporate Actions 
No Upcoming Board Meetings
Chemfab Alkalis Ltd has declared 12% dividend, ex-date: 04 Sep 25
No Splits history available
No Bonus history available
No Rights history available
Quality key factors 
Valuation key factors
Technicals key factors
Shareholding Snapshot : Dec 2025
Shareholding Compare (%holding) 
Promoters
None
Held by 2 Schemes (0.07%)
Held by 2 FIIs (0.08%)
Dr Rao Holdings Pte Ltd (47.04%)
V. M. Srinivasan (1.8%)
21.56%
Quarterly Results Snapshot (Consolidated) - Dec'25 - QoQ
QoQ Growth in quarter ended Dec 2025 is -11.00% vs -16.36% in Sep 2025
QoQ Growth in quarter ended Dec 2025 is -121.39% vs -178.82% in Sep 2025
Annual Results Snapshot (Consolidated) - Mar'25
YoY Growth in year ended Mar 2025 is 2.16% vs -1.23% in Mar 2024
YoY Growth in year ended Mar 2025 is -126.37% vs -59.24% in Mar 2024






